BNT327-03 – A Phase III, multisite, double-blinded randomized trial of BNT327 in combination with chemotherapy (etoposide/carboplatin) compared to atezolizumab in combination with chemotherapy (etoposide/carboplatin) in participants with first-line extensive-stage small-cell lung cancer (BNT327-03)

Principal Investigator

Dr Nicholas Coupe

Contact us

Email: latephaseoncology@ouh.nhs.uk

IRAS number

1011017